Estimating the Prevalence of Sexual Dysfunction Using the New ICD-11 Guidelines.
Journal
Deutsches Arzteblatt international
ISSN: 1866-0452
Titre abrégé: Dtsch Arztebl Int
Pays: Germany
ID NLM: 101475967
Informations de publication
Date de publication:
25 Sep 2020
25 Sep 2020
Historique:
received:
01
04
2020
revised:
01
04
2020
accepted:
11
08
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
2
2
2021
Statut:
ppublish
Résumé
The 11 The representative GeSiD study was carried out in 4955 men and women who belonged to a doubly stratified random sample of data from residence registration offices across Germany. The participation rate was 30.2%. Various types of sexual dysfunction were ascertained for the first time by means of a screening instrument based on the new ICD-11 guidelines. The reported prevalence of one or more sexual problems, including mild distress, in the previous 12 months was 33.4% in men (95% confidence interval [31.0; 35.9]) and 45.7% in women [43.0; 48.4]. Some 80.4% of men and 72.1% of women stated that they had had at least one sexual contact in the past year. Sexual dysfunction causing marked distress, as per the ICD-11 guidelines, was reported by 13.3% [11.6; 15.1] of the sexually active men (most commonly, erectile dysfunction in 6.6% and early ejaculation in 4.5%), and by 17.5% [15.6; 19.6] of the sexually active women (most commonly, hypoactive sexual desire in 6.9% and orgasmic dysfunction in 5.8%). Orgasmic dysfunction was approximately twice as common in women as delayed ejaculation was in men. The prevalence of erectile dysfunction increased with age, while that of early ejaculation decreased. Women felt particularly impaired by pain associated with sexual activity. The findings of this study indicate the importance of sexual dysfunction as an obstacle to sexual health. The study provides the first prevalence estimates for the new ICD-11 guidelines and simultaneously offers a screening instrument for sexual dysfunction that can be used economically in routine practice.
Sections du résumé
BACKGROUND
BACKGROUND
The 11
METHODS
METHODS
The representative GeSiD study was carried out in 4955 men and women who belonged to a doubly stratified random sample of data from residence registration offices across Germany. The participation rate was 30.2%. Various types of sexual dysfunction were ascertained for the first time by means of a screening instrument based on the new ICD-11 guidelines.
RESULTS
RESULTS
The reported prevalence of one or more sexual problems, including mild distress, in the previous 12 months was 33.4% in men (95% confidence interval [31.0; 35.9]) and 45.7% in women [43.0; 48.4]. Some 80.4% of men and 72.1% of women stated that they had had at least one sexual contact in the past year. Sexual dysfunction causing marked distress, as per the ICD-11 guidelines, was reported by 13.3% [11.6; 15.1] of the sexually active men (most commonly, erectile dysfunction in 6.6% and early ejaculation in 4.5%), and by 17.5% [15.6; 19.6] of the sexually active women (most commonly, hypoactive sexual desire in 6.9% and orgasmic dysfunction in 5.8%). Orgasmic dysfunction was approximately twice as common in women as delayed ejaculation was in men. The prevalence of erectile dysfunction increased with age, while that of early ejaculation decreased. Women felt particularly impaired by pain associated with sexual activity.
CONCLUSION
CONCLUSIONS
The findings of this study indicate the importance of sexual dysfunction as an obstacle to sexual health. The study provides the first prevalence estimates for the new ICD-11 guidelines and simultaneously offers a screening instrument for sexual dysfunction that can be used economically in routine practice.
Identifiants
pubmed: 33357346
pii: arztebl.2020.0653
doi: 10.3238/arztebl.2020.0653
pmc: PMC7829447
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
653-658Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Références
Lancet. 2013 Nov 30;382(9907):1830-44
pubmed: 24286788
Sex Med Rev. 2016 Jul;4(3):197-212
pubmed: 27871953
Nat Rev Dis Primers. 2016 Feb 04;2:16003
pubmed: 27188339
Int J Impot Res. 1999 Sep;11 Suppl 1:S60-4
pubmed: 10554933
J Sex Med. 2016 Apr;13(4):650-68
pubmed: 27045262
BMJ. 2010 Sep 30;341:c5050
pubmed: 20884702
Eur Urol Focus. 2020 Jul 15;6(4):776-790
pubmed: 30878347
Maturitas. 2016 Dec;94:87-91
pubmed: 27823751
J Sex Res. 2012;49(4):311-8
pubmed: 22720822
World Psychiatry. 2016 Oct;15(3):205-221
pubmed: 27717275
Sex Med Rev. 2016 Apr;4(2):103-120
pubmed: 27872021
BMJ. 2002 Apr 13;324(7342):886-91
pubmed: 11950740
J Sex Med. 2016 Feb;13(2):144-52
pubmed: 26953829
J Sex Res. 2016 Oct;53(8):955-967
pubmed: 26605494